Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€24.38
31.10.23
-
31.10.24
15.46%
17:43

investresearch 
31.10.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
31.10.23
-
31.10.24
-18.31%
20.11.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
31.10.23 50%
sell
Affimed N.V.

Start price
Target price
Perf. (%)
€0.29
28.10.23
-
28.10.24
89.77%
08.03.24

StockNews.com 
28.10.23 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€33.12
11.10.23
-
11.10.24
14.79%
12.12.23

Known brand
Could be worthwhile Investment >10% per year
fenjal 
11.10.23 50%
sell
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€38.99
04.10.23
€22.00
04.10.24
-16.75%
14.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
kostojunior 
04.10.23 0%
sell
Paion AG

Start price
Target price
Perf. (%)
€0.68
04.10.23
€0.000
04.10.24
-
11.04.23

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
kostojunior 
04.10.23 0%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.45
25.09.23
€6.61
25.09.24
23.49%
08.03.24

Cantor Fitzgerald 
25.09.23 50%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.76
19.09.23
€6.00
19.09.24
-1.68%
30.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
19.09.23 30%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€29.49
12.09.23
-
12.09.24
35.54%
31.01.24

Saftman 
12.09.23 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.49
07.09.23
€6.54
07.09.24
12.95%
08.03.24

Cantor Fitzgerald 
07.09.23 50%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.79
07.09.23
-
07.09.24
-4.59%
16.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
07.09.23 70%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.01
03.09.23
-
03.09.24
-19.80%
05.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
03.09.23 0%
sell
ifa systems AG

Start price
Target price
Perf. (%)
€3.16
20.08.23
€0.000
20.08.24
-5.70%
03.09.23

Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
dimontalban 
20.08.23 70%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.51
11.08.23
€4.56
11.08.24
9.18%
08.03.24

HC Wainwright 
11.08.23 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€46.77
08.08.23
-
08.08.24
-23.22%
31.01.24

Saftman 
08.08.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.39
07.08.23
€54.00
07.08.24
-35.42%
21.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
07.08.23 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.28
06.08.23
-
06.08.24
-12.50%
20.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
06.08.23 0%
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€2.30
04.08.23
-
04.08.24
-23.70%
12:28

DirectorDealer 
04.08.23 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€48.33
27.07.23
€57.00
27.07.24
-19.22%
17:23

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
gerihouse 
27.07.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.86
20.07.23
€25.00
20.07.24
-42.60%
17.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
20.07.23 50%
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€260.00
18.07.23
€300.00
18.07.24
-13.56%
17:29

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Max1111 
18.07.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.93
10.07.23
€55.00
10.07.24
-42.21%
17:41

Could be worthwhile Investment >10% per year
melinda 
10.07.23 20%
sell
Biofrontera AG

Start price
Target price
Perf. (%)
€0.78
04.07.23
€0.000
04.07.24
-56.27%
17:44

Could be very worthwhile Investment >20% year
Undervalued
kostojunior 
04.07.23 0%
sell
Medigene AG

Start price
Target price
Perf. (%)
€1.87
24.06.23
€1.00
24.06.24
-20.91%
16:38

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
24.06.23 60%
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.60
23.06.23
-
0.18%
23.06.23

Could be worthwhile Investment >10% per year
Wolf_of_WS 
23.06.23 50%